Photanol BV, a Dutch company that has developed technology to produce circular carbon chemicals from CO2 absorbed from the air and Renolit SE, a manufacturer of high-quality polymer films, sheets and other polymer solutions, have formed a strategic partnership to develop new sustainably-produced polymers.
The new resins are intended for the needs of Renolit Healthcare, ‘but also for other applications of our Group’, said Renolit board member and general manager Healthcare, Thomas Sampers.
“This partnership is bringing a long series of benefits to our healthcare customers and patients, amongst which fully sustainable raw materials, better quality of medical devices due to higher purity of the raw materials and a secured supply-chain,” he added.
Photanol will develop and manufacture monomers for the production of fully sustainable polymers based on CO2 absorbed from the air in a direct, fully circular and CO2 -neutral, fossil-free conversion process. Compared to traditional bio-based technologies, the chosen pathway also dramatically reduces the need for land and water.
Photanol’s process is based on photosynthesis, utilising proprietary engineered cyanobacteria, which make use of energy from the sun and carbon dioxide to produce sustainable chemicals and oxygen.
Teaming up with Renolit helps us to bring this fascinating disruptive technology to many markets at competitive cost while taking care of the planet,” concluded Veronique de Bruijn, CEO of Photanol.